AAAAAA

   
Results: 1-8 |
Results: 8
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
Authors: McDermott, DH Halcox, JPJ Schenke, WH Waclawiw, MA Merrell, MN Epstein, N Quyyumi, AA Murphy, PM
Citation: Dh. Mcdermott et al., Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis, CIRCUL RES, 89(5), 2001, pp. 401-407
Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis
Authors: Prasad, A Koh, KK Schenke, WH Mincemoyer, R Csako, G Fleischer, TA Brown, M Selvaggi, TA Quyyumi, AA
Citation: A. Prasad et al., Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosis, AM HEART J, 142(2), 2001, pp. 248-253
Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women
Authors: Blum, A Hathaway, L Mincemoyer, R Schenke, WH Kirby, M Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: A. Blum et al., Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation in healthy postmenopausal women, J AM COL C, 35(2), 2000, pp. 271-276
Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women
Authors: Blum, A Cannon, RO Costello, R Schenke, WH Csako, G
Citation: A. Blum et al., Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women, J LA CL MED, 135(3), 2000, pp. 231-237
Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis
Authors: Prasad, A Tupas-Habib, T Schenke, WH Mincemoyer, R Panza, JA Waclawin, MA Ellahham, S Quyyumi, AA
Citation: A. Prasad et al., Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis, CIRCULATION, 101(20), 2000, pp. 2349-2354
Oral L-arginine in patients with coronary artery disease on medical management
Authors: Blum, A Hathaway, L Mincemoyer, R Schenke, WH Kirby, M Csako, G Waclawiw, MA Panza, JA Cannon, RO
Citation: A. Blum et al., Oral L-arginine in patients with coronary artery disease on medical management, CIRCULATION, 101(18), 2000, pp. 2160-2164
Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women
Authors: Blum, A Schenke, WH Hathaway, L Mincemoyer, R Csako, G Waclawiw, MA Cannon, RO
Citation: A. Blum et al., Effects of estrogen and the selective estrogen receptor modulator raloxifene on markers of inflammation in postmenopausal women, AM J CARD, 86(8), 2000, pp. 892
Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator Raloxifene in hypercholesterolemic men
Authors: Blum, A Hathaway, L Mincemoyer, R Schenke, WH Csako, G Waclawiw, MA Panza, JA Connon, RO
Citation: A. Blum et al., Hormonal, lipoprotein, and vascular effects of the selective estrogen receptor modulator Raloxifene in hypercholesterolemic men, AM J CARD, 85(12), 2000, pp. 1491
Risultati: 1-8 |